Drug Information

Drug General Information
Drug ID
D00ZEG
Former ID
DIB010017
Drug Name
Umespirone
Synonyms
KC-7218; KC-9172
Drug Type
Small molecular drug
Indication Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] Phase 1 [544712]
Company
Solvay SA
Formula
C28H40N4O5
Canonical SMILES
C12C(=O)N(C(=O)C(C(=O)N(C1=O)CCCCN1CCN(c3c(OC)cccc3)CC1<br />)C2(C)C)CCCC
CAS Number
CAS 107736-98-1
PubChem Compound ID
65902
Target and Pathway
Target(s) D(2) dopamine receptor Target Info Antagonist [528329]
5-hydroxytryptamine 1A receptor Target Info Antagonist [528329]
KEGG Pathway Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholismhsa04024:cAMP signaling pathway
Serotonergic synapse
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathway
Reactome Dopamine receptors
G alpha (i) signalling eventsR-HSA-390666:Serotonin receptors
G alpha (i) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic NeuronsWP722:Serotonin HTR1 Group and FOS Pathway
SIDS Susceptibility Pathways
References
Ref 544712Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000698)
Ref 528329The effects of umespirone as a potential anxiolytic and antipsychotic agent. Pharmacol Biochem Behav. 1991 Sep;40(1):89-96.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.